{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-050785","form_type":"8-K","ticker":"SRTA","cik":"0001779128","company_name":"Strata Critical Medical, Inc.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.411453+00:00","generated_at":"2026-05-16T22:31:30.720619+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Strata Critical Medical Q3 revenue up 36.7% to $49.3M; net loss widens to $9.7M","bullets":["Revenue $49.3M, up 36.7% YoY; organic growth 29.0% excluding Keystone acquisition.","Net loss from continuing ops $(9.7)M, widened from $(5.6)M in prior-year period.","Medical Segment Adjusted EBITDA $7.6M, +93.5% YoY; margin 15.3% (up 450 bps).","Raised FY2025 revenue guidance to $185-195M; reaffirmed Adjusted EBITDA range.","Investor Day on Nov 17, 2025 to introduce FY2026 guidance and medium-term targets."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-050785","json":"https://secwatch.observer/filing/0001628280-25-050785.json","markdown":"https://secwatch.observer/filing/0001628280-25-050785.md","text":"https://secwatch.observer/filing/0001628280-25-050785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779128/000162828025050785/0001628280-25-050785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779128/000162828025050785/srta-20251110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:31:30.720619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}